{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T07:51:59Z","timestamp":1791445919969,"version":"4.3.3"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,11]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>\n                      Ewing sarcoma (EwS) is the second most common malignant bone tumour in children and adolescents. Due to its highly aggressive nature, rapid and accurate initial diagnosis as well as reliable recurrence detection are essential for treatment planning. Standard diagnostic work-up includes MRI for local tumour assessment and whole-body MRI or\n                      <jats:sup>18<\/jats:sup>\n                      F-fluorodeoxyglucose-PET\u2013computed tomography (\n                      <jats:sup>18<\/jats:sup>\n                      F-FDG-PET\/CT) for metastatic evaluation.\n                      <jats:sup>18<\/jats:sup>\n                      F-FDG-PET\/MRI combines the soft-tissue contrast of MRI with the metabolic information of PET while reducing radiation exposure. As data on PET\/MRI in EwS are limited, we assessed its accuracy in primary staging and recurrence detection in a high-volume sarcoma center.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      In this monocentric retrospective study, whole-body\n                      <jats:sup>18<\/jats:sup>\n                      F-FDG-PET\/MRI scans of 38 therapy-na\u00efve EwS patients were analyzed for local and distant tumor spread. Additional scans of 43 EwS patients were evaluated for recurrence. PET\/MRI findings were compared with whole-body MRI alone and a composite reference standard by two independent readers. Sensitivity and specificity were calculated.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>PET\/MRI showed higher sensitivity than MRI alone for lymph node metastases in both initial (91.7% vs. 25%) and follow-up staging (100% vs. 33.3%), with equally high specificity (96.8%). PET\/MRI also showed slightly higher sensitivity for soft-tissue recurrence (100% vs. 90%). No difference between PET\/MRI and MRI was found for bone or lung lesions, although both were less sensitive than chest CT (60% vs. 100%).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      <jats:sup>18<\/jats:sup>\n                      F-FDG-PET\/MRI is a feasible tool for both primary and follow-up imaging of EwS, providing excellent local tumor evaluation and high sensitivity for metastases and recurrence. However, chest CT remains necessary for small lung lesion detection.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/mnm.0000000000002196","type":"journal-article","created":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T14:01:24Z","timestamp":1781532084000},"page":"1249-1257","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Diagnostic value of integrated 18F-fluorodeoxyglucose PET\/MRI in initial staging and recurrence detection of Ewing sarcoma"],"prefix":"10.1097","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-9825-3136","authenticated-orcid":false,"given":"Marcel Alexander","family":"Drews","sequence":"first","affiliation":[{"name":"Institute of Diagnostic and Interventional Radiology and Neuroradiology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandar","family":"Milosevic","sequence":"additional","affiliation":[{"name":"Institute of Diagnostic and Interventional Radiology and Neuroradiology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Zensen","sequence":"additional","affiliation":[{"name":"Institute of Diagnostic and Interventional Radiology and Neuroradiology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel","family":"Opitz","sequence":"additional","affiliation":[{"name":"Institute of Diagnostic and Interventional Radiology and Neuroradiology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lale","family":"Umutlu","sequence":"additional","affiliation":[{"name":"Institute of Diagnostic and Interventional Radiology and Neuroradiology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang Peter","family":"Fendler","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Forsting","sequence":"additional","affiliation":[{"name":"Institute of Diagnostic and Interventional Radiology and Neuroradiology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Herrmann","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uta","family":"Dirksen","sequence":"additional","affiliation":[{"name":"Pediatrics III, University Hospital Essen, German Cancer Consortium (DKTK) Site Essen, Cancer Research Center (NCT) Cologne-Essen, Essen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedikt Michael","family":"Schaarschmidt","sequence":"additional","affiliation":[{"name":"Institute of Diagnostic and Interventional Radiology and Neuroradiology"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,6,12]]},"reference":[{"key":"R1-20261008","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S1470-2045(09)70286-4","article-title":"Ewing\u2019s sarcoma.","volume":"11","author":"Balamuth","year":"2010","journal-title":"Lancet Oncol"},{"key":"R2-20261008","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.3390\/jcm10081685","article-title":"Ewing sarcoma-diagnosis, treatment, clinical challenges and future perspectives.","volume":"10","author":"Zollner","year":"2021","journal-title":"J Clin Med"},{"key":"R3-20261008","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/S0140-6736(22)01790-1","article-title":"Comparison of two chemotherapy regimens in patients with newly diagnosed Ewing sarcoma (EE2012): an open-label, randomised, phase 3 trial.","volume":"400","author":"Brennan","year":"2022","journal-title":"Lancet"},{"key":"R4-20261008","doi-asserted-by":"crossref","first-page":"3284","DOI":"10.1200\/JCO.2009.22.9864","article-title":"Primary disseminated multifocal Ewing sarcoma: results of the Euro-EWING 99 trial.","volume":"28","author":"Ladenstein","year":"2010","journal-title":"J Clin Oncol"},{"key":"R5-20261008","doi-asserted-by":"crossref","first-page":"e96751","DOI":"10.1371\/journal.pone.0096751","article-title":"Correlation of standardized uptake value and apparent diffusion coefficient in integrated whole-body PET\/MRI of primary and recurrent cervical cancer.","volume":"9","author":"Grueneisen","year":"2014","journal-title":"PLoS One"},{"key":"R6-20261008","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1002\/pbc.23040","article-title":"Risk of recurrence and survival after relapse in patients with Ewing sarcoma.","volume":"57","author":"Stahl","year":"2011","journal-title":"Pediatr Blood Cancer"},{"key":"R7-20261008","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/1471-2474-10-125","article-title":"Relevance of MRI in prediction of malignancy of musculoskeletal system \u2013 a prospective evaluation.","volume":"10","author":"Daniel","year":"2009","journal-title":"BMC Musculoskelet Disord"},{"key":"R8-20261008","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s40134-017-0207-y","article-title":"How PET\/MR can add value for children with cancer.","volume":"5","author":"Daldrup-Link","year":"2017","journal-title":"Curr Radiol Rep"},{"key":"R9-20261008","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1053\/j.semnuclmed.2016.12.004","article-title":"The role of (18)F-FDG-PET\/CT in pediatric sarcoma.","volume":"47","author":"Harrison","year":"2017","journal-title":"Semin Nucl Med"},{"key":"R10-20261008","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1016\/j.annonc.2021.08.1995","article-title":"Bone sarcomas: ESMO-EURACAN-GENTURIS-ERN PaedCan Clinical Practice Guideline for diagnosis, treatment and follow-up.","volume":"32","author":"Strauss","year":"2021","journal-title":"Ann Oncol"},{"key":"R11-20261008","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1158\/1078-0432.CCR-11-2139","article-title":"18F-FDG-PET\/CT Imaging as an early survival predictor in patients with primary high-grade soft tissue sarcomas undergoing neoadjuvant therapy.","volume":"18","author":"Herrmann","year":"2012","journal-title":"Clin Cancer Res"},{"key":"R12-20261008","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.2967\/jnumed.119.233940","article-title":"PET\/MRI versus PET\/CT for whole-body staging: results from a single-center observational study on 1,003 sequential examinations.","volume":"61","author":"Martin","year":"2020","journal-title":"J Nucl Med"},{"key":"R13-20261008","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.3390\/diagnostics12102278","article-title":"Utility of integrated PET\/MRI for the primary diagnostic work-up of patients with ewing sarcoma: preliminary results.","volume":"12","author":"Chodyla","year":"2022","journal-title":"Diagnostics (Basel)"},{"key":"R14-20261008","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s00247-020-04834-7","article-title":"Clinical utilization of whole-body PET\/MRI in childhood sarcoma.","volume":"51","author":"Qi","year":"2021","journal-title":"Pediatr Radiol"},{"key":"R15-20261008","doi-asserted-by":"crossref","first-page":"127","DOI":"10.5152\/dir.2016.15610","article-title":"Is integrated 18F-FDG PET\/MRI superior to 18F-FDG PET\/CT in the differentiation of incidental tracer uptake in the head and neck area?","volume":"23","author":"Schaarschmidt","year":"2017","journal-title":"Diagn Interv Radiol"},{"key":"R16-20261008","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s00259-015-3145-z","article-title":"Locoregional tumour evaluation of squamous cell carcinoma in the head and neck area: a comparison between MRI, PET\/CT and integrated PET\/MRI.","volume":"43","author":"Schaarschmidt","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R17-20261008","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.clinimag.2016.11.016","article-title":"FDG PET\/MR in initial staging of sarcoma: Initial experience and comparison with conventional imaging.","volume":"42","author":"Platzek","year":"2017","journal-title":"Clin Imaging"},{"key":"R18-20261008","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.clinimag.2015.05.014","article-title":"(18)F-FDG PET\/MRI for therapy response assessment in sarcoma: comparison of PET and MR imaging results.","volume":"39","author":"Schuler","year":"2015","journal-title":"Clin Imaging"},{"key":"R19-20261008","doi-asserted-by":"crossref","first-page":"e29415","DOI":"10.1002\/pbc.29415","article-title":"(18) F-FDG PET and PET\/CT as a diagnostic method for Ewing sarcoma: a systematic review and meta-analysis.","volume":"69","author":"Seth","year":"2022","journal-title":"Pediatr Blood Cancer"},{"key":"R20-20261008","doi-asserted-by":"crossref","first-page":"102151","DOI":"10.1016\/j.suronc.2024.102151","article-title":"Diagnostic accuracy and treatment benefit of PET\/CT in staging of colorectal cancer compared to conventional imaging.","volume":"57","author":"Engel","year":"2024","journal-title":"Surg Oncol"},{"key":"R21-20261008","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1007\/s12149-022-01795-9","article-title":"Consistency and prognostic value of preoperative staging and postoperative pathological staging using 18F-FDG PET\/MRI in patients with non-small cell lung cancer.","volume":"36","author":"Kajiyama","year":"2022","journal-title":"Ann Nucl Med"},{"key":"R22-20261008","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s13139-016-0411-3","article-title":"FDG whole-body PET\/MRI in oncology: a systematic review.","volume":"51","author":"Kwon","year":"2016","journal-title":"Nucl Med Mol Imaging"},{"key":"R23-20261008","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1093\/jnci\/djp514","article-title":"Detection of lymph node metastases by gadolinium-enhanced magnetic resonance imaging: systematic review and meta-analysis.","volume":"102","author":"Klerkx","year":"2010","journal-title":"J Natl Cancer Inst"},{"key":"R24-20261008","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/jmri.26183","article-title":"Applications of PET-MRI in musculoskeletal disease.","volume":"48","author":"Kogan","year":"2018","journal-title":"J Magn Reson Imaging"},{"key":"R25-20261008","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1007\/s00259-013-2388-9","article-title":"Diagnostic accuracy of 18F-FDG PET\/CT for detecting recurrence in patients with primary skeletal Ewing sarcoma.","volume":"40","author":"Sharma","year":"2013","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R26-20261008","doi-asserted-by":"crossref","first-page":"e13457","DOI":"10.1097\/MD.0000000000013457","article-title":"Effectiveness of 18F-FDG PET\/CT in the diagnosis, staging and recurrence monitoring of Ewing sarcoma family of tumors: A meta-analysis of 23 studies.","volume":"97","author":"Huang","year":"2018","journal-title":"Medicine (Baltim)"},{"key":"R27-20261008","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/MNM.0000000000000407","article-title":"18F-FDG PET-CT in soft tissue sarcomas: staging, restaging, and prognostic value?","volume":"37","author":"Gabriel","year":"2016","journal-title":"Nucl Med Commun"},{"key":"R28-20261008","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1148\/radiol.13130620","article-title":"Pulmonary nodules in patients with primary malignancy: comparison of hybrid PET\/MR and PET\/CT imaging.","volume":"268","author":"Chandarana","year":"2013","journal-title":"Radiology"},{"key":"R29-20261008","doi-asserted-by":"crossref","first-page":"5435","DOI":"10.1200\/JCO.2007.12.2473","article-title":"Positron emission tomography for staging of pediatric sarcoma patients: results of a prospective multicenter trial.","volume":"25","author":"Vo\u0308lker","year":"2007","journal-title":"J Clin Oncol"},{"key":"R30-20261008","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1148\/radiol.14131732","article-title":"Simultaneous whole-body PET\/MR Imaging in Comparison to PET\/CT in Pediatric Oncology: Initial Results.","volume":"273","author":"Sch\u00e4fer","year":"2014","journal-title":"Radiology"},{"key":"R31-20261008","doi-asserted-by":"crossref","first-page":"3454","DOI":"10.3390\/cancers14143454","article-title":"Lung nodules missed in initial staging of breast cancer patients in PET\/MRI-clinically relevant?","volume":"14","author":"Jannusch","year":"2022","journal-title":"Cancers (Basel)"},{"key":"R32-20261008","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1002\/jmri.29802","article-title":"Magnetic resonance imaging in the clinical evaluation of lung disorders: current status and future prospects.","volume":"62","author":"Wu","year":"2025","journal-title":"J Magn Reson Imaging"},{"key":"R33-20261008","doi-asserted-by":"crossref","first-page":"109987","DOI":"10.1016\/j.ejrad.2021.109987","article-title":"PET\/MRI in paediatric disease.","volume":"144","author":"Sepehrizadeh","year":"2021","journal-title":"Eur J Radiol"},{"key":"R34-20261008","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ejrad.2013.05.028","article-title":"Competitive advantage of PET\/MRI.","volume":"83","author":"Jadvar","year":"2014","journal-title":"Eur J Radiol"}],"container-title":["Nuclear Medicine Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MNM.0000000000002196","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T07:00:37Z","timestamp":1791442837000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MNM.0000000000002196"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,12]]},"references-count":34,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/mnm.0000000000002196","relation":{},"ISSN":["0143-3636","1473-5628"],"issn-type":[{"value":"0143-3636","type":"print"},{"value":"1473-5628","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,12]]},"assertion":[{"value":"2026-03-18","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-01","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}